Revance Therapeutics
RVNC
#7470
Rank
HK$2.49 B
Marketcap
HK$23.92
Share price
0.00%
Change (1 day)
-65.31%
Change (1 year)

Market capitalization of Revance Therapeutics (RVNC)

Market cap: HK$2.49 Billion

As of December 2024 Revance Therapeutics has a market cap of HK$2.49 Billion. This makes Revance Therapeutics the world's 7470th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Revance Therapeutics from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$2.49 B-58.57%
2023HK$6.02 B-49.2%
2022HK$11.86 B29.88%
2021HK$9.13 B-37.51%
2020HK$14.62 B120.85%
2019HK$6.62 B13.58%
2018HK$5.82 B-42.61%
2017HK$10.15 B121.88%
2016HK$4.57 B-38.89%
2015HK$7.48 B139.76%
2014HK$3.12 B

End of Day market cap according to different sources

On Dec 25th, 2024 the market cap of Revance Therapeutics was reported to be:

HK$2.50 Billion
by Nasdaq info icon info icon
HK$2.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$0.74 B-70.25%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.722 T 108,913.45%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$169.66 B 6,693.73%๐Ÿ‡บ๐Ÿ‡ธ USA